Compare DH & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DH | AIRS |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 112.1M | 182.4M |
| IPO Year | 2021 | 2021 |
| Metric | DH | AIRS |
|---|---|---|
| Price | $1.12 | $1.33 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 7 | 3 |
| Target Price | $1.90 | ★ $4.50 |
| AVG Volume (30 Days) | 554.4K | ★ 812.7K |
| Earning Date | 11-05-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $241,521,000.00 | $151,818,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.65 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.61 | $1.24 |
| 52 Week High | $3.02 | $12.00 |
| Indicator | DH | AIRS |
|---|---|---|
| Relative Strength Index (RSI) | 72.26 | 22.78 |
| Support Level | $0.90 | N/A |
| Resistance Level | $1.22 | $3.31 |
| Average True Range (ATR) | 0.04 | 0.13 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 96.08 | 0.64 |
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.